Induction of immunological tolerance to single-stranded and double-stranded DNA

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Autoimmune diseases like systemic lupus erythematosus (SLE) are characterized by the production of autoantibodies against self-components, including DNA.
• Current treatments for SLE often have significant side effects and limited efficacy.

Purpose of the Study:

• To investigate the potential of DNA-conjugated copolymers as a novel therapeutic strategy for inducing immune tolerance in autoimmune conditions.
• To evaluate the efficacy of single-stranded (ss) and double-stranded (ds) DNA conjugated with d-glutamic acid and d-lysin (d-GL) in preventing autoantibody production.

Main Methods:

• Conjugation of ssDNA and dsDNA with d-GL copolymers.
• Administration of DNA-d-GL conjugates to C3H/H3 and NZB/W F1 mouse models.
• Assessment of anti-DNA antibody titres and antibody-forming cells.
• In vitro stability assessment of induced tolerance.

Main Results:

• Administration of ss-DNA-d-GL conjugates induced tolerance to both direct and indirect anti-ss-DNA antibody responses.
• Repeated administration of ss-DNA- or ds-DNA-d-GL conjugates reduced anti-ss-DNA and anti-ds-DNA antibody titres and antibody-forming cells.
• Tolerance was DNA-specific and remained stable at the cellular level post-tolerogen removal, even in aged mice with established lupus nephritis.

Conclusions:

• DNA-d-GL conjugates can effectively induce stable, DNA-specific immune tolerance.
• This approach shows promise as a therapeutic strategy for treating systemic lupus erythematosus by modulating autoantibody production.